Economy

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Under Analyst Spotlight

PNM Resources has $43.0 highest and $26 lowest target. They set a "buy" rating and a $98.00 target price on the stock. Bunge Limited had 26 analyst reports since July 31, 2015 according to SRatingsIntel.

BioMarin Pharmaceutical (NASDAQ:BMRN) last issued its earnings results on Wednesday, August 2nd. On Tuesday, November 29 the stock rating was downgraded by Barclays Capital to "Equal-Weight". The firm earned "Hold" rating on Monday, August 15 by Desjardins Securities. The rating was maintained by Wedbush with "Neutral" on Tuesday, January 19. The firm has "Buy" rating by BMO Capital Markets given on Thursday, July 6. The stock has "Buy" rating by Jefferies on Monday, September 25. The company was initiated on Friday, October 23 by BMO Capital Markets. Citigroup maintained the shares of BG in report on Wednesday, July 12 with "Buy" rating. As per Friday, August 14, the company rating was upgraded by Vetr. The stock has "Hold" rating by Evercore on Wednesday, January 6. Neuberger Berman Group LLC now owns 161,196 shares of the biotechnology company's stock worth $14,150,000 after acquiring an additional 2,298 shares during the last quarter. The SI to Biomarin Pharma Incorporated's float is 4.68%. Company insiders own 1.85% of the company's stock.

Amid volatile financial markets and the presidential election, various investment brokerages have made amendments to their price targets and ratings on shares of BioMarin Pharmaceutical Inc. The 50 day moving average was up by +6.67% whereas the 200 day moving average was up $5.67 or +6.32%. It has underperformed by 11.41% the S&P500.

The stock increased 0.25% or $0.1 during the last trading session, reaching $40.75. It is down 0.00% since October 6, 2016 and is. It has underperformed by 11.41% the S&P500.

Investors sentiment increased to 1.26 in 2017 Q2. Its down 0.44, from 1.24 in 2017Q1. It is positive, as 8 investors sold Valener Inc shares while 1 reduced holdings. Thrivent Financial For Lutherans reported 413,315 shares or 0.07% of all its holdings. Prudential Public Ltd reported 0.12% stake. Ameritas Partners Incorporated owns 3,126 shares for 0.01% of their portfolio. State Street Corp boosted its stake in shares of BioMarin Pharmaceutical by 6.9% during the 1st quarter. Bessemer Grp reported 0% stake. First Citizens Bankshares Tru accumulated 10,941 shares. 168.09 million shares or 1.78% more from 165.15 million shares in 2017Q1 were reported. Engineers Gate Manager Lp reported 41,237 shares. Jpmorgan Chase And, a New York-based fund reported 128,272 shares. Finally, TIAA CREF Investment Management LLC boosted its stake in shares of BioMarin Pharmaceutical by 63.7% during the 2nd quarter. Manufacturers Life Insur Comm The accumulated 175,431 shares. Focused Wealth has invested 0% in Valener Inc (TSE:VNR). Dimensional Fund Advisors Limited Partnership owns 0.03% invested in PNM Resources Inc (NYSE:PNM) for 1.63M shares.

Analysts await PNM Resources Inc (NYSE:PNM) to report earnings on October, 27 before the open. On average, equities analysts anticipate that BioMarin Pharmaceutical Inc. will post ($0.71) earnings per share for the current fiscal year. EPS ratio determined by looking at last 12 month figures is 0.26. The biotechnology company reported ($0.21) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.22) by $0.01. The company has market cap of $3.25 billion.

Investors sentiment increased to 0.11 in 2017 Q2. Its up 0.06, from 1.2 in 2017Q1. Morgan Stanley maintained BioMarin Pharmaceutical Inc. 51 funds opened positions while 134 raised stakes. About 32.66 million shares traded or 9.93% up from the average. The biotechnology company reported $0.03 EPS for the quarter, topping analysts' consensus estimates of ($0.30) by $0.33. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Investment owns 0.09% invested in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) for 12,257 shares. Captrust Fincl Advsr holds 740 shares or 0% of its portfolio. Pub Employees Retirement Association Of Colorado reported 33,756 shares or 0.02% of all its holdings. Northern Trust holds 0.03% or 1.10 million shares in its portfolio. Following the sale, the executive vice president now directly owns 49,299 shares of the company's stock, valued at approximately $4,683,405. Renaissance Ltd Liability Corporation reported 0.01% of its portfolio in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) on Tuesday, February 23 with "Perform" rating. Port Solutions Ltd Co, a Michigan-based fund reported 29 shares. Oppenheimer maintained BioMarin Pharmaceutical Inc.

The company is up by 0.98%% since yesterday's close of 94.42.

On 09/15/2017, RBC Capital Markets released a statement for BioMarin Pharmaceutical (NDAQ:BMRN) bumped up the target price from $0.00 to $93.00 that suggested an upside of 0.01%. Mutual of America Capital Management LLC grew its position in BioMarin Pharmaceutical by 20.0% during the 1st quarter.

07/20/2017 - BioMarin Pharmaceutical Inc. had its "outperform" rating reiterated by analysts at Leerink Swann. (NASDAQ:BMRN). Nippon Life Insur Co owns 11,828 shares or 0.02% of their U.S. portfolio. 302 BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.is a biotechnology company. Hussman Strategic Advisors Inc who had been investing in Bunge Limited for a number of months, seems to be bullish on the $9.66 billion market cap company. The Company develops and commercializes pharmaceuticals for various diseases and medical conditions. It now has negative earnings. As of December 31, 2016, the Company's therapy portfolio consisted of five products, and multiple clinical and pre-clinical product candidates.

Since April 28, 2017, it had 0 buys, and 14 insider sales for $7.91 million activity. The insider BIENAIME JEAN JACQUES sold 10,000 shares worth $901,300. (NASDAQ:BMRN) shares were sold by FUCHS HENRY J. $687,334 worth of stock was sold by Mueller Brian on Friday, April 28. The stock of BioMarin Pharmaceutical Inc. LAWLIS V BRYAN sold $337,500 worth of stock.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



Like this

Latest


07 October 2017
LeBron to miss second exhibition game with sprained ankle
James sprained his left ankle September 27 and hasn't played in either of the Cavs' two preseason games - both losses. The Cavs will head to the nation's capital on Sunday for a date with the Washington Wizards.

07 October 2017
Major fire engulfs oil depot off India's Mumbai coast
According to officials, the fire broke out in two fuel storage tanks. The firefighting operation to douse the flames is still underway.

07 October 2017
Navios Maritime Holdings Inc. (NYSE:NM) Under Analyst Spotlight
Whatever the strategy, staying in tune with fundamentals and meaningful economic data may also prove to be highly beneficial. A certain stock may be considered to be on an uptrend if trading above a moving average and the average is sloping upward.

07 October 2017
Spain qualify for 11th consecutive World Cup
La Roja ensured qualification for next year's event in Russian Federation by winning 3-0 at home to Albania in Alicante. Their qualification was confirmed, after Italy could manage only a 1-1 draw at home to Macedonia .

07 October 2017
Apple IPhone 8 Has Battery Issue
Liu bought the device from JD.com which means Apple itself will not help him out (according to the paper). Investors are concerned that the pre-orders this time will be less than the previous iPhones.

07 October 2017
United States gun lobby agrees to target 'bump stocks' after Las Vegas massacre
In the case of Buck, the longtime Weld County District Attorney said through an aide that he's only now learned of the device. Carlos Curbelo told ABC News that he hoped to introduce bipartisan legislation to ban bump stocks as soon as Thursday.

07 October 2017
There's a Mass Shooting Almost Every Day in the US
Patrick Henry Sherrill, 44, was a part-time postman who returned to his office a day after receiving a "poor performance" review. To give you an idea of just how many guns are floating around the nation with the most mass shootings, take a look at this.

07 October 2017
Insider Trading at Thor Industries Inc.?
Camarda Advsrs Ltd Liability stated it has 0.02% of its portfolio in Thor Industries, Inc . (NYSE:CMI) or 25,110 shares. It is positive, as 48 investors sold Thor Industries, Inc . shares while 127 reduced holdings. (NYSE:THO).

07 October 2017
Doctor who replaced disgraced USC medical school dean is out
The Times also reported receiving a statement from the University on October 4 defending Varma. "We carefully considered Dr. The Keck School is hosting an event Friday at noon in a location that had not been determined at time of publication.

07 October 2017
Ready to join NDA, Narayan Rane says
He is a prominent leader from the influential Maratha community and hails from Sindhudurg district of the Konkan region. Announcing his move, Rane was quoted by the Indian Express as saying, "I have taken the decision to join the NDA".



Recommended